» Articles » PMID: 6723636

Efficacy of Continuous Versus Intermittent Administration of Penicillin G in Streptococcus Pneumoniae Pneumonia in Normal and Immunodeficient Rats

Overview
Specialty Microbiology
Date 1984 Apr 1
PMID 6723636
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

An experimental Streptococcus pneumoniae pneumonia was used to study the influence of continuous versus intermittent administration of penicillin G on therapeutic efficacy in normal rats and in rats whose phagocytic capacities were impaired by decomplementation with cobra venom factor. Response to antibiotic treatment was evaluated with respect to numbers of bacteria in left lung, blood and pleural fluid. Penicillin treatment was started 36 h after bacterial inoculation, and continued for four days. With intermittent intramuscular administration of penicillin normal rats were cured after daily doses of 4 mg/kg at 12 h intervals, whereas decomplemented rats recovered only after daily doses of 100 or 102 mg/kg at 12 h or 8 h intervals, respectively. When penicillin was administered by way of continuous infusion, daily doses of 3.5 mg/kg were required for a cure of infections in both normal rats and in decomplemented rats. This treatment resulted in a constant level of 0.05 micrograms of penicillin per ml, which was slightly above the minimum bactericidal concentration for the infecting strain. These findings show that maintenance of bactericidal levels of penicillin were particularly important in curing severe infection in rats with impaired defense.

Citing Articles

Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.

Grupper M, Kuti J, Nicolau D Clin Microbiol Rev. 2016; 29(4):759-72.

PMID: 27413094 PMC: 5010748. DOI: 10.1128/CMR.00022-16.


Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.

Goulenok T, Fantin B Clin Pharmacokinet. 2013; 52(10):869-83.

PMID: 23807657 DOI: 10.1007/s40262-013-0086-1.


Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.

Bakker-Woudenberg I, Ten Kate M, Goessens W, Mouton J Antimicrob Agents Chemother. 2006; 50(9):2919-25.

PMID: 16940082 PMC: 1563558. DOI: 10.1128/AAC.00859-05.


Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection.

Lau W, Mercer D, Itani K, Nicolau D, Kuti J, Mansfield D Antimicrob Agents Chemother. 2006; 50(11):3556-61.

PMID: 16940077 PMC: 1635208. DOI: 10.1128/AAC.00329-06.


Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusion.

Berkhout J, Visser L, van den Broek P, van de Klundert J, Mattie H Antimicrob Agents Chemother. 2003; 47(6):1862-6.

PMID: 12760859 PMC: 155817. DOI: 10.1128/AAC.47.6.1862-1866.2003.


References
1.
NORDBRING F . Current practice in penicillin dosing. J Antimicrob Chemother. 1981; 8 Suppl C:1-6. DOI: 10.1093/jac/8.suppl_c.1. View

2.
Michel M . Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis. Infect Immun. 1979; 25(1):366-75. PMC: 414461. DOI: 10.1128/iai.25.1.366-375.1979. View

3.
Peterson L, Gerding D, Fasching C . Effects of method of antibiotic administration on extravascular penetration: cross-over study of cefazolin given by intermittent injection or constant infusion. J Antimicrob Chemother. 1981; 7(1):71-9. DOI: 10.1093/jac/7.1.71. View

4.
Barza M, Brusch J, Bergeron M, WEINSTEIN L . Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid. J Infect Dis. 1974; 129(1):73-8. DOI: 10.1093/infdis/129.1.73. View

5.
Kunin C . Dosage schedules of antimicrobial agents: a historical review. Rev Infect Dis. 1981; 3(1):4-11. DOI: 10.1093/clinids/3.1.4. View